2025-05-29 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co (CL), focusing on the provided data.

**Report on Colgate-Palmolive Co (CL)**

**0. Summary Statistics**

*   **Ticker:** CL
*   **Company Name:** Colgate-Palmolive Co
*   **Current Price:** $91.76

**1. Performance vs. S&P 500 (VOO)**

*   **CL Cumulative Return:** 24.44%
*   **VOO Cumulative Return:** 82.09%
*   **Spread:** -57.65%
*   **Relative Spread Position:** 9.8 (This indicates CL's underperformance is near the lower end of its historical range relative to VOO.)

**Analysis:** Colgate-Palmolive (CL) has significantly underperformed the S&P 500 (VOO) over the period analyzed. The large negative spread indicates substantial underperformance, with a relative spread position indicating that this underperformance is near the worst levels historically observed.

Here's a table summarizing Alpha, Beta, CAGR, and MDD over different periods:

| Year       | CAGR    | MDD     | Alpha    | Beta  | Cap(B) |
|------------|---------|---------|----------|-------|--------|
| 2015-2017  | 13.0%   | 4.8%    | -16.0%   | 0.1   | 51.2   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%   | 0.1   | 41.4   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%   | 0.2   | 49.1   |
| 2018-2020  | 18.0%   | 65.2%   | -8.0%    | 0.7   | 62.4   |
| 2019-2021  | 30.0%   | 58.6%   | -25.0%   | 1.0   | 63.7   |
| 2020-2022  | 8.0%    | 69.0%   | 1.0%     | 1.0   | 60.2   |
| 2021-2023  | 8.0%    | 69.0%   | -9.0%    | 0.9   | 62.5   |
| 2022-2024  | 15.0%   | 69.0%   | -2.0%    | 0.8   | 72.8   |
| 2023-2025  | 11.0%   | 62.4%   | -19.0%   | 0.3   | 74.4   |

**Analysis:**

*   **Alpha:**  The consistent negative alpha values (except for 2020-2022) indicate that CL has generally underperformed its benchmark on a risk-adjusted basis.
*   **Beta:**  The beta values, which are generally below 1, suggest that CL's price is less volatile than the overall market.
*   **CAGR:** Compound Annual Growth Rate shows varied performance across different periods.
*   **MDD:** Maximum Drawdown shows significant drawdowns, particularly from 2016-2024.

**Colgate-Palmolive Co. is a global consumer products company specializing in the production and distribution of household, healthcare, and personal care products.**

**2. Recent Price Action**

*   **Last Price:** $91.76
*   **Previous Close:** $92.43
*   **Change:** -$0.72
*   **5-Day Moving Average:** 91.87
*   **20-Day Moving Average:** 90.76
*   **60-Day Moving Average:** 91.65

**Analysis:** The current price is slightly below the 5-day moving average and 20-day moving average, but above the 60-day moving average.  The small price decrease indicates a slight downward trend.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 53.88 (Neutral)
*   **PPO:** 0.30 (Neutral)
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Spread Change:** 1.6 (+): Short-term increase
*   **Expected Return:** -345.3%

**Analysis:**

*   **MRI:** Suggests the overall market risk is currently low.
*   **RSI & PPO:** Indicate neutral momentum.
*   **Hybrid Signal:** Indicates a moderate buy signal based on current technicals, but with a caution flag due to the MRI value.
*   **Recent Relative Spread Change:** Indicates a short-term improvement in CL's performance relative to the benchmark, but this might be just a short-term fluctuation.
*   **Expected Return:** The significantly negative expected return is a major red flag, suggesting that long-term investment in CL might significantly underperform the S&P 500.
*   **Price Change:** The recent small price change of -0.72 suggests a minor downward move but doesn't necessarily indicate a significant volatility event.

**4. Recent News & Events**

*   **[2025-05-27]:** Business developments, regulatory changes, or market events.
*   **[2025-05-26]:** Analyst discussions on performance and outlook.
*   **[2025-05-25]:** Stock volatility influenced by news, earnings, or executive actions.
*   **[2025-05-29]:** Experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news snippets point to several factors affecting CL's stock: business developments, analyst scrutiny, and stock volatility influenced by recent events.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-04-25 | 0.85 | 4.91 B$ |
| 2024-10-25 | 0.90 | 5.03 B$ |
| 2024-07-26 | 0.89 | 5.06 B$ |
| 2024-04-26 | 0.83 | 5.07 B$ |
| 2025-04-25 | 0.83 | 5.07 B$ |

**Analysis:**

*   **EPS:** EPS has fluctuated but generally remained relatively stable. The most recent EPS of 0.85 is slightly lower than previous periods.
*   **Revenue:** Revenue has also remained relatively consistent, with a slight downward trend in the most recent quarter.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $4.91B  | 60.82%        |
| 2024-12-31   | $4.95B  | 60.30%        |
| 2024-09-30   | $5.03B  | 61.08%        |
| 2024-06-30   | $5.06B  | 60.62%        |
| 2024-03-31   | $5.07B  | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-03-31   | $0.36B  | 190.08%   |
| 2024-12-31   | $0.21B  | 348.58%   |
| 2024-09-30   | $0.43B  | 169.43%   |
| 2024-06-30   | $0.12B  | 594.31%   |
| 2024-03-31   | $0.23B  | 296.96%   |

**Analysis:**

*   **Revenue and Profitability:**
    *   Revenue shows a slight decrease over the past year.
    *   Profit margins are consistently high, indicating strong operational efficiency.
*   **Capital and Profitability:**
    *   Equity fluctuates significantly.
    *   ROE (Return on Equity) is exceptionally high, suggesting that Colgate-Palmolive is highly efficient in generating profits from shareholder equity, but the fluctuating equity values raise questions about the consistency of this efficiency.

**7. Overall Analysis**

Colgate-Palmolive (CL) presents a mixed picture:

*   **Underperformance:**  CL has significantly underperformed the S&P 500 historically and is projected to continue to underperform based on the very negative expected return.
*   **Stable but Declining Revenue:** Revenue and EPS are relatively stable, but recent quarters show a slight downward trend.
*   **High Profitability:**  The company maintains strong profit margins, indicating efficient operations.
*   **Volatile ROE:**  The extremely high but volatile ROE suggests some potential inconsistencies or unusual items affecting the company's equity and profitability metrics.
*   **Neutral Technicals:** Technical indicators (RSI, PPO) are neutral.
*   **Low Market Risk:** The MRI suggests that the overall market risk is low.
*   **Recent News:** Indicates business developments, analyst scrutiny, and potential stock volatility.

**Conclusion:**

Based on this analysis, Colgate-Palmolive (CL) may not be a particularly attractive investment at this time, especially when compared to the broader market (S&P 500). The historical underperformance, the negative projected return, and the slightly declining revenue trends raise concerns. While the company exhibits high profitability, the high volatility of ROE and declining revenues are red flags. However, the low MRI and potential business developments might offer opportunities. Investors should closely monitor the company's financial performance, news releases, and analyst reports before making any investment decisions. The buy signal generated by the hybrid signal should be treated cautiously due to the negative expected return and historical underperformance.
